|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Non-cash interest income on liability related to the sale of future royalties | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Non-cash revenue related to sale of future payments | |||||
| Non-cash interest expense on liability related to sale of future payments | |||||
| Depreciation and amortization | |||||
| Net amortization of discount on short term investments | |||||
| Non-cash interest expense related to debt financing | |||||
| Revaluation of liability for Lowell holdback shares | |||||
| Stock-based compensation | |||||
| Impairment of property and equipment | |||||
| Gain on change in fair value of warrant liability | |||||
| Impairment of net assets held for sale | |||||
| Impairment of fixed assets | |||||
| Accounts receivable | |||||
| Gain on extinguishment of debt liability | |||||
| Other | |||||
| Inventories | |||||
| Revaluation of warrant liability | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Sale of the DSUVIA assets | |||||
| Cash paid for asset acquisition, net of cash acquired | |||||
| Purchase of investments | |||||
| Proceeds from sale of investments | |||||
| Proceeds from maturities of investments | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Payment of long-term debt | |||||
| Net proceeds from issuance of Series A Redeemable Convertible Preferred Stock and Warrants | |||||
| Redemption of Series A Redeemable Convertible Preferred Stock | |||||
| Gross proceeds from sale of future payments | |||||
| Issuance costs related to sale of future payments | |||||
| Net proceeds from issuance of common stock in connection with exercise of pre-funded warrants | |||||
| Payment of employee tax obligations related to vesting of restricted stock units | |||||
| Net proceeds from issuance of common stock through equity plans | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents—Beginning of period | |||||
| Cash and cash equivalents—End of period | |||||
| Cash paid for interest | |||||
| Income taxes paid | |||||
| Noncash Investing and Financing Activities: | |||||
| Purchases of property and equipment in accounts payable and accrued expenses | |||||
| Equity issuance costs from warrant modification | |||||
| Equity issuance costs in accounts payable and accrued expenses | |||||
| Settlement of held back shares issued in connection with asset acquisition | |||||
| Issuance of common stock in connection with asset acquisition | |||||
| Establishment of right-of-use asset and lease liability | |||||
| Offering costs in accounts payable and accrued liabilities | |||||
| Fair value of warrants issued to placement agent | |||||
Loading...